7Baggers
 Nurix Therapeutics (NASDAQ:NRIX) Shares Up 4.6% - Time to Buy?  MarketBeat Fri, 26 Sep 2025 18:32:02 GMT
 nurix therapeutics’ swot analysis: promising pipeline drives biotech stock outlook  Investing.com Australia Tue, 23 Sep 2025 01:03:59 GMT
 nurix therapeutics (nasdaq:nrix) trading up 6.5% - time to buy?  MarketBeat Sun, 21 Sep 2025 09:13:57 GMT
 Nurix Therapeutics (NASDAQ:NRIX) Shares Up 6.5% - Should You Buy?  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 nurix therapeutics (nasdaq:nrix) shares up 6.5% - time to buy?  MarketBeat Sat, 20 Sep 2025 17:46:14 GMT
 published on: 2025-09-19 19:28:52  خودرو بانک Fri, 19 Sep 2025 15:59:45 GMT
 published on: 2025-09-19 16:56:26  خودرو بانک Fri, 19 Sep 2025 13:28:03 GMT
 Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus  The Globe and Mail Fri, 19 Sep 2025 11:10:00 GMT
 Nurix Therapeutics (NRIX) Gets a Buy from Barclays  The Globe and Mail Fri, 19 Sep 2025 07:26:00 GMT
 nurix therapeutics (nasdaq:nrix) shares up 6.5% - time to buy?  MarketBeat Thu, 18 Sep 2025 19:52:20 GMT
 Nurix Therapeutics presents data from GS-6791  TipRanks Wed, 17 Sep 2025 07:00:00 GMT
 gild partners with nurix for potential irak4 protein degrader  GuruFocus Wed, 17 Sep 2025 07:00:00 GMT
 nurix therapeutics (nasdaq:nrix) shares down 6.5% - here's why  MarketBeat Sun, 14 Sep 2025 02:18:13 GMT
 nurix therapeutics (nasdaq:nrix) shares down 6.5% - here's why  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 Nurix Therapeutics to Participate in Upcoming Investor Conferences  Investing News Network Thu, 11 Sep 2025 23:51:03 GMT
 nurix therapeutics (nasdaq:nrix) shares down 6.5% - here's why  MarketBeat Thu, 11 Sep 2025 18:13:58 GMT
 nurix therapeutics (nasdaq:nrix) trading down 6.5% - what's next?  MarketBeat Thu, 11 Sep 2025 18:13:58 GMT
 nurix therapeutics : investor deck baird  MarketScreener Tue, 09 Sep 2025 07:00:00 GMT
 Nurix Therapeutics : investor deck HCW Final  MarketScreener Mon, 08 Sep 2025 07:00:00 GMT
 invesco ltd. increases position in nurix therapeutics, inc. $nrix  MarketBeat Sun, 07 Sep 2025 03:40:00 GMT
 invesco ltd. increases position in nurix therapeutics, inc. $nrix  MarketBeat Fri, 05 Sep 2025 22:55:44 GMT
 published on: 2025-09-05 13:16:55  Newser Fri, 05 Sep 2025 18:16:55 GMT
 invesco ltd. grows position in nurix therapeutics, inc. $nrix  MarketBeat Thu, 04 Sep 2025 22:19:21 GMT
 nuveen llc makes new investment in nurix therapeutics, inc. $nrix  MarketBeat Thu, 04 Sep 2025 22:10:32 GMT
 nurix therapeutics to discuss bexobrutideg developments  The Globe and Mail Thu, 04 Sep 2025 12:30:00 GMT
 nurix therapeutics, inc. $nrix shares sold by redmile group llc  MarketBeat Thu, 04 Sep 2025 11:39:44 GMT
 tema etfs llc increases stake in nurix therapeutics, inc. $nrix  MarketBeat Thu, 04 Sep 2025 09:02:46 GMT
 nuveen llc invests $2.01 million in nurix therapeutics, inc. $nrix  MarketBeat Thu, 04 Sep 2025 02:18:25 GMT
 Nurix Therapeutics to Discuss Bexobrutideg Developments  TipRanks Wed, 03 Sep 2025 07:00:00 GMT
 tema etfs llc increases stake in nurix therapeutics, inc. $nrix  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT
 nuveen llc invests $2.01 million in nurix therapeutics, inc. $nrix  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT
 nurix therapeutics (nasdaq:nrix) raised to strong-buy at baird r w  MarketBeat Tue, 02 Sep 2025 04:00:00 GMT
 nuveen llc invests $2.01 million in nurix therapeutics, inc. $nrix  MarketBeat Mon, 01 Sep 2025 07:36:09 GMT
 nurix therapeutics (nasdaq:nrix) raised to strong-buy at baird r w  MarketBeat Mon, 01 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 07:19:32  Newser Sun, 31 Aug 2025 12:19:32 GMT
 nurix therapeutics, inc. $nrix shares acquired by tema etfs llc  MarketBeat Sun, 31 Aug 2025 10:30:00 GMT
 nurix therapeutics, inc. $nrix shares acquired by tema etfs llc  MarketBeat Sat, 30 Aug 2025 15:28:25 GMT

Nurix Therapeutics, Inc
(NASDAQ:NRIX) 

NRIX stock logo

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader with immunomodul...

Founded: 2009
Full Time Employees: 122
CEO: Arthur T. Sands  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends